✦ LIBER ✦

Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study

✍ Scribed by Strumberg, D; Scheulen, M E; Schultheis, B; Richly, H; Frost, A; Büchert, M; Christensen, O; Jeffers, M; Heinig, R; Boix, O; Mross, K

Book ID: 111951892
Publisher: Nature Publishing Group
Year: 2012
Tongue: English
Weight: 394 KB
Volume: 106
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.2012.153

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I Dose-Escalation Study of Regor

A Phase I Dose-Escalation Study of Regorafenib (BAY 73-4506), an Inhibitor of Oncogenic, Angiogenic, and Stromal Kinases, in Patients with Advanced Solid Tumors

✍ Mross, K.; Frost, A.; Steinbild, S.; Hedbom, S.; Buchert, M.; Fasol, U.; Unger, 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 392 KB

1236 POSTER Phase I Study to Assess the

1236 POSTER Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of the Multikinase Inhibitor Regorafenib (BAY 73-4506) in Japanese Patients With Advanced Solid Tumours

✍ J. Furuse; Y. Sasaki; T. Okusaka; M. Ikeda; F. Nagashima; Y. Sunakawa; H. Ueno; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

6576 POSTER Phase II Safety Study of the

6576 POSTER Phase II Safety Study of the Oral Multikinase Inhibitor Regorafenib (BAY 73-4506) as Second-line Therapy in Patients With Hepatocellular Carcinoma

✍ Bolondi, L.; Tak, W.Y.; Gasbarrini, A.; Santoro, A.; Colombo, M.; Lim, H.Y.; Maz 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

7141 POSTER Phase II Trial of the Oral M

7141 POSTER Phase II Trial of the Oral Multikinase Inhibitor Regorafenib (BAY 73-4506) as First-line Therapy in Patients With Metastatic or Unresectable Renal Cell Carcinoma (RCC)

✍ Eisen, T.; Joensuu, H.; Nathan, P.; Harper, P.; Wojtukiewicz, M.; Nicholson, S.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Phase I-II study of ftorafur and methyl-

Phase I-II study of ftorafur and methyl-ccnu in advanced colorectal cancer

✍ Robert J. Belt; Ronald Stephens 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB 👁 2 views

The combination of Ftorafur (NSC-148958) and methyl-CCNU (NSC-95441) was evaluated in 36 patients with advanced colorectal cancer. The principle toxicities encountered were myelosuppression, gastrointestinal, and neurological. There were no complete responses and only 5/34 (14.7%) patients achieved

Phase II study of didemnin B in advanced

Phase II study of didemnin B in advanced colorectal cancer

✍ Dennie V. Jones; Jaffer A. Ajani; Roxann Blackburn; Karen Daugherty; Bernard Lev 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 222 KB